{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-028775","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2026-06-15T23:44:44+00:00","discovered_at":"2026-06-16T10:05:00.310514+00:00","generated_at":"2026-06-16T10:06:17.267452+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"medium","headline":"Vivos enters collaboration with Florida cardiology group to launch AIM Florida sleep apnea venture","bullets":["Vivos expects to hold ≥80% membership interest in AIM Florida; SPCVA up to 20%, subject to definitive docs.","SPCVA is a multi-location cardiology practice with ~30,000 patients; initial focus on Palm Beach County.","One fully staffed team is planned to serve ~250 patients/month, projecting >$6M annual revenue and ~50% contribution margin.","Model based on Vivos' successful Nevada sleep centers but requires no upfront capital outlay.","Definitive operating agreement and ancillary contracts remain to be negotiated; no assurance of completion."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-028775","json":"https://secwatch.observer/filing/0001493152-26-028775.json","markdown":"https://secwatch.observer/filing/0001493152-26-028775.md","text":"https://secwatch.observer/filing/0001493152-26-028775.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226028775/0001493152-26-028775-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226028775/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T10:06:17.267452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"426a18d2bb38e5403838deb5dddc43477aa51ec2","claim":"Vivos Therapeutics, Inc. entered into Collaboration Agreement with South Palm Cardiovascular Associates, LLC valued at Formation of new management services organization AIM Florida, LLC; Vivos holds not less than 80% me (effective 2026-06-10).","evidence_excerpt":"On June 10, 2026, Vivos Therapeutics, Inc. (the “Company”) entered into a Collaboration Agreement (the “Collaboration Agreement”) with South Palm Cardiovascular Associates, LLC, a Florida limited liability company (“SPCVA”), pursuant to which the parties agreed to collaborate in the formation and operation of a new management services organization to be known as AIM Florida, LLC (“AIM Florida”). AIM Florida is intended to provide administrative, operational, billing, payer-contracting, marketing, platform, data and other non-clinical support services to one or more affiliated professional clinical entities that will deliver sleep apnea diagnostic and treatment services to patients, with the collaboration initially focused on the Palm Beach County, Florida market. Under the Collaboration Agreement, the Company expects to hold not less than 80% of the membership interests in AIM Florida, and SPCVA expects to hold up to 20% of the membership interests, in each case subject to the negotiat","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226028775/0001493152-26-028775-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"collaboration"},{"label":"Counterparty","value":"South Palm Cardiovascular Associates, LLC"},{"label":"Value","value":"Formation of new management services organization AIM Florida, LLC; Vivos holds not less than 80% me"},{"label":"Effective","value":"2026-06-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}